SVEP1 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with SVEP1 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with SVEP1 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with SVEP1 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SVEP1 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000111215 - proline rich 4

Gene

ENSG00000142684 - zinc finger protein 593

Gene

ENSG00000134594 - RAB33A, member RAS oncogene family

Gene

ENSG00000105289 - tight junction protein 3

Gene

ENSG00000107014 - relaxin 2

Gene

ENSG00000184113 - claudin 5

Gene

ENSG00000175324 - LSM1 homolog, mRNA degradation associated

Gene

ENSG00000103363 - elongin B

Gene

ENSG00000165060 - frataxin

Gene

ENSG00000121897 - lipoic acid synthetase

  • Gene

    ENSG00000111215 - proline rich 4


  • Gene

    ENSG00000142684 - zinc finger protein 593


  • Gene

    ENSG00000134594 - RAB33A, member RAS oncogene family


  • Gene

    ENSG00000105289 - tight junction protein 3


  • Gene

    ENSG00000107014 - relaxin 2


  • Gene

    ENSG00000184113 - claudin 5


  • Gene

    ENSG00000175324 - LSM1 homolog, mRNA degradation associated


  • Gene

    ENSG00000103363 - elongin B


  • Gene

    ENSG00000165060 - frataxin


  • Gene

    ENSG00000121897 - lipoic acid synthetase

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.